home.aspx
 
EVENTS

Health Informatic Technologies
HEALTH INFORMATIC TECHNOLOGIES
November 02-03, 2020
Health Informatic Technologies aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Health Informatic Technologies. It also provides a premier interdisciplinary platform for researchers, p...

International Conference on Machine Learning and Big Data for Healthcare
INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND BIG DATA FOR HEALTHCARE
November 05-06, 2020
International Conference on Machine Learning and Big Data for Healthcare aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Machine Learning and Big Data for Healthcare. It also provides...

Bristol Hospital and Health Care Group, Inc.

SHARESHARESHARE
Founded in 1921, Bristol Hospital is the leading health provider for people who live and work in the greater Bristol area. Proud of its achievements in service excellence, Bristol Hospital has earned national recognition for its commitment to providing outstanding patient care. Bristol Hospital has 154 licensed beds and offers a complete range of patient services including a first-rate emergency center, a 50,000 sq. ft. state-of-the-art surgical center, a family-centered, single-room-model maternity unit, an award-winning ICU, Ingraham Manor skilled nursing facility, the Beekley Center for Breast Health & Wellness, Sleep Center, Center for Orthopedic and Spine Health, cardiac and pulmonary rehabilitation, the Connecticut Gastroenterology Institute, inpatient and outpatient behavioral health services, and an advanced Diagnostic Imaging department offering the latest in CT/PET, MRI and nuclear medicine.
SHARESHARESHARE

RELATED NEWS


RARITAN, NJ – July 26, 2016 -- Janssen Biotech, Inc. announced today it has entered into a clinical study collaboration agreement with Bristol-Myers Squibb Company to evaluate the combination of two immuno-oncology compounds in patients with non-small cell lung cancer (NSCLC). The Phase 2 clinical trial will evaluate the tolerability and clinical activity of the combination of Janssen’s investigational immunotherapy JNJ-64041757 and Bristol-Myer Squibb’s PD-1 immune checkpoint inhibitor, OPDIV...
JOHNSON & JOHNSON
READ MORE

CHICAGO: A new type of cancer drug that takes the brakes off the body's immune system has given drugmakers some remarkable wins against the deadly disease, but a top U.S. regulator says too many companies are focused on the same approach…...
ECONOMICTIMES
READ MORE

EVENTS

Health Informatic Technologies
HEALTH INFORMATIC TECHNOLOGIES
November 02-03, 2020
Health Informatic Technologies aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Health Informatic Technologies. It also provides a premier interdisciplinary platform for researchers, p...

International Conference on Machine Learning and Big Data for Healthcare
INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND BIG DATA FOR HEALTHCARE
November 05-06, 2020
International Conference on Machine Learning and Big Data for Healthcare aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Machine Learning and Big Data for Healthcare. It also provides...